SHC Evergreen is a medicare approved dialysis facility center in San Jose, California and it has 25 dialysis stations. It is located in Santa Clara county at 3251 South White Road, Suite 10, San Jose, CA, 95148. You can reach out to the office of SHC Evergreen at (408) 766-6500. This dialysis clinic is managed and/or owned by Us Renal Care, Inc.. SHC Evergreen has the following ownership type - Non-profit. It was first certified by medicare in April, 2019. The medicare id for this facility is 552859 and it accepts patients under medicare ESRD program.
| Name | SHC Evergreen |
|---|---|
| Location | 3251 South White Road, Suite 10, San Jose, California |
| No. of Dialysis Stations | 25 |
| Medicare ID | 552859 |
| Managed By | Us Renal Care, Inc. |
| Ownership Type | Non-profit |
| Late Shifts | No |
| 3251 South White Road, Suite 10, San Jose, California, 95148 | |
| (408) 766-6500 | |
| Dialysis patients with Hemoglobin data | 28 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 21 |
For adult patients on hemodialysis, Kt/V should be at least 1.2 and for peritoneal dialysis at least 1.7; that means they are receiving the right amount of dialysis. For pediatric patients, Kt/V should be at least 1.2 on hemodialysis and 1.8 on peritoneal dialysis.
Higher percentages are better.
| Adult patients getting regular hemodialysis at the center | 62 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 557 |
| Percentage of adult hemodialysis patients with Kt/V greater than or equal to 1.2 | 90 |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at SHC Evergreen with elevated calcium levels.
| Patients in the hypercalcemia summary | 63 |
| Hypercalcemia patient months | 563 |
| Patients in the serum phosphorus summary | 68 |
| Percentage of patients with serum phosphorus less than 3.5 mg/dL | 11 |
| Percentage of patients with serum phosphorus from 3.5 to 4.5 mg/dL | 20 |
| Percentage of patients with serum phosphorus from 4.6 to 5.5 mg/dL | 25 |
| Percentage of patients with serum phosphorus from 5.6 to 7 mg/dL | 28 |
| Percentage of patients with serum phosphorus greater than 7 mg/dL | 16 |
The arteriovenous (AV) fistula is considered the best long-term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arteriovenous fistula and catheter summaries | 67 |
| Patient months included in arteriovenous fistula and catheter summaries | 593 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistula for their treatment | 67.1 |
| Percentage of patients receiving treatment through a vascular catheter for 90 days or longer | 18 |
The rate of hospitalization shows you whether patients who were being treated regularly at SHC Evergreen were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standardized Hospitalization Ratio (SHR) Period | January, 2024 - December, 2024 |
| Patients in facility's Hospitalization Summary | 51 |
| Hospitalization Rate in facility | 124 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 210.7 |
| Hospitalization Rate: Lower Confidence Limit | 78.4 |
The rate of readmission shows you whether patients who were being treated regularly at SHC Evergreen were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standardized Readmission Ratio (SRR) Period | January, 2024 - December, 2024 |
| Readmission Rate in facility | 22.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 39.1 |
| Readmission Rate: Lower Confidence Limit | 10 |
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether SHC Evergreen's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standardized Transfusion Ratio (STrR) Period | January, 2024 - December, 2024 |
| Patients in facility's Transfusion Summary | 26 |
| Transfusion Rate in facility | 24.4 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 105.5 |
| Transfusion Rate: Lower Confidence Limit | 8 |
The rate of mortality shows you whether patients who were being treated regularly at SHC Evergreen lived longer than expected (better than expected), did not live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standardized Mortality Ratio (SMR) Period | January, 2021 - December, 2024 |
| Patients in facility's Survival Summary | 212 |
| Mortality Rate in facility | 13.2 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 22.1 |
| Mortality Rate: Lower Confidence Limit | 7.8 |
Davita Cornerhouse Dialysis Center Location: 2005 Naglee Avenue, San Jose, California, 95128 Phone: (408) 998-0183 |
Davita Eastridge Dialysis Location: 3501 E Capitol Expressway, San Jose, California, 95122 Phone: (408) 929-2274 |
Davita Silicon Valley Dialysis Location: 725 Ridder Park., Ste 10, San Jose, California, 95131 Phone: (408) 392-0390 |
Davita Silicon Valley Home Training Location: 725 Ridder Park Dr., Ste 50, San Jose, California, 95131 Phone: (408) 392-0239 |
Davita Stevens Creek Dialysis Location: 275 Di Salvo Ave, San Jose, California, 95128 Phone: (408) 297-0103 |